The Osteopathic Medical Board of California (OMBC) held a significant meeting on November 14, 2024, where key updates and initiatives were discussed that directly impact the community and healthcare professionals across the state.

One of the most notable announcements was the upcoming increase in fees for the Controlled Substance Utilization Review and Evaluation System (CURES), effective April 1, 2025. The annual fee will rise from $9 to $15, resulting in a biannual cost of $30 for licensees. This change aims to enhance the operational capabilities of the CURES system, which is crucial for monitoring prescription drug use and preventing abuse. The board plans to communicate these changes effectively to all stakeholders, ensuring that licensees are well-informed.

In addition to financial updates, the board is actively working on improving public outreach and education. Recent collaborations with the Consumer Watchdog Group have led to the development of a virtual tutorial video aimed at helping consumers understand how to file complaints effectively. This initiative reflects the board's commitment to transparency and consumer protection, as highlighted by positive feedback from community members during the meeting.

The board also discussed ongoing efforts to enhance communication and collaboration with various organizations, including the Department of Justice and the California Department of Public Health. These partnerships are essential for aligning regulatory measures and improving the overall healthcare landscape in California.

Furthermore, the board is focusing on engaging with students and healthcare professionals to clarify the board's role and responsibilities. Recent outreach events, such as health fairs and residency conferences, have provided opportunities for board members to connect with the community and educate future osteopathic physicians about the importance of compliance and ethical practice.

As the year comes to a close, the OMBC is poised to implement these initiatives, which aim to strengthen the board's presence in the community and enhance the support provided to both healthcare professionals and consumers. The board's proactive approach to outreach and education is expected to foster a better understanding of its functions and encourage more informed participation from the public.